Alzheimer’s Disease and Related Disorders (ADRD) are public health crises and critical areas of scientific effort. The National Institutes of Health, Alzheimer’s Association, and other federal, state, and non-profit funders of research are investing heavily in the science of ADRD in an effort to curb the impact of these debilitating, burdensome, and costly disorders. Tremendous advances made in understanding the pathobiology of disease will ultimately have one final pathway to impacting clinical care and public health – randomized controlled clinical trials.
IMPACT-AD was founded to train the next generation of ADRD clinical trialists, to ensure that investments in discovery yield outcomes for patients and families. Our goal is to provide education and tools to establish a global cohort of qualified investigators to guide the field toward improved therapies. IMPACT-AD will be successful if it produces an outstanding, well-trained, and knowledgeable cohort of collaborative investigators who will carry the mantle of the National Plan to Address AD.
IMPACT-AD will leverage the outstanding collection of investigators, including members of the ACTC and beyond. National and international leaders in ADRD trials will gather annually to provide a unique, interactive, cutting edge educational experience in ADRD trials.
IMPACT-AD 2026 is now accepting applications. Individuals with broad ranging experience and expertise in AD/ADRD and/or clinical trials who are interested in a career in AD/ADRD clinical trials are encouraged to apply. IMPACT-AD will cover all participation and travel costs for accepted trainees.
Two unique in-person tracks will be offered as part of IMPACT-AD 2026. Tracks will commence simultaneously and overlap. Please read the eligibility criteria for each track carefully and ensure your qualifications align appropriately.
Professionals Track (3.5 days)
This track seeks applications from individuals with at least 2 years of experience in AD/ADRD research and/or clinical trials who wish to deepen their knowledge and advance their careers in AD/ADRD clinical trials. Applicants may currently serve in a variety of roles including, but not limited to, clinicians, study coordinators, statisticians, psychometricians, and other study professionals.
Fellowship Track (5 days)
This track seeks applications from individuals seeking to serve as Principal Investigators in AD/ADRD trials now or in the future and offers mentored training in protocol development. Applications are open to individuals in their fellowship or postdoctoral training, faculty members, or any equivalent positions.
Participation is competitive and open to individuals with a full-time position at their respective institution within the United States. Please read the eligibility criteria for each track carefully and ensure your qualifications align appropriately. Applicants are permitted to apply to only one track per application cycle.
Application Submission requirements:
- NIH Biosketch (both tracks)
- A career statement (both tracks)
- Institutional letter of support (both tracks)
- Brief trial protocol synopsis (Fellowship Track only) (template online). Mentors/PIs may submit only one recommendation per track. As an applicant, it is your responsibility to confirm that your recommender is not providing a recommendation for another individual applying to the same track.
All materials must be submitted electronically through ProposalCentral by 5:00PM PST April 30, 2026. Attendees will be selected after expert peer review of application materials and notified in early June 2026. Priority will be given to applicants whose career statement, institutional letter of support, and (if applicable) quality of the proposed research synopsis (significance, innovation, and approach) demonstrate a commitment to pursuing a career in AD/ADRD clinical trials research.
Participation in the Global Program: If your place of residence and primary appointment are outside of the United States, you might be eligible for our IMPACT-AD global program within the Fellowship Track. If interested, please email your CV/Biosketch and a Letter of Support to our IMPACT-AD Program Email Address, and include “IMPACT-AD 2026 Global Eligibility” in the subject of your email. Your materials will be reviewed, and you will be notified regarding your eligibility to apply.Please do not submit an application to ProposalCentral unless your eligibility has been reviewed via this mechanism.If you do not receive a response within a week, please email us again.
All submission templates and instructions are located in the Course Details tab of this website. If you have any questions regarding the application or the IMPACT-AD Course, contact us here. Good luck on your application!
